Filters








41,837 Hits in 1.2 sec

Prostate Cancer and Prostate Cancer Stem Cells [chapter]

Magdalena E. Buczek, Jerome C. Edwards, Tarik Regad
2015 Principles of Stem Cell Biology and Cancer  
The TE forms placental tissue and membranes, while the Principles of Stem Cell Biology and Cancer: Future Applications and Therapeutics, First Edition. Edited by Tarik Regad, Thomas J.  ...  Some abnormalities enriched in hESC cultures are also found in tumours and might therefore carry a higher risk of inducing cancer-like changes.  ...  It is of note that this will deprive the host of any means of immune detection, should such cells carry abnormalities that could cause cancer.  ... 
doi:10.1002/9781118670613.ch10 fatcat:hcjzvvzecjfl5cj4hphekuzeou

Prostate cancer

John Masters
2003 British Journal of Cancer  
Is there someone whom you want to give a generous (about d100) Christmas or birthday present to who treats prostate cancer?  ...  Of course, many of the top names in prostate cancer do live and work in California and have contributed chapters.  ... 
doi:10.1038/sj.bjc.6600962 pmcid:PMC2377152 fatcat:fqhhifswa5cllhq2iqx23yu7gu

Prostatic cancer

A Rostom
1976 BMJ (Clinical Research Edition)  
GILLIAN TURNER University Department of Obstetrics and Gynaecology, Bristol Maternity Hospital, Bristol Prostatic cancer SIR,-In your leading article on this subject (28 August, p 490) you did not mention  ...  I write to make a plea for continued screening for breast cancer.  ... 
doi:10.1136/bmj.2.6041.942-b pmid:974677 pmcid:PMC1688449 fatcat:grlrxlao4jaynjcou76axcue7y

Prostate cancer

Ricardo Alonso Castillejos-Molina, Fernando Bernardo Gabilondo-Navarro
2016 Salud Pública de México  
salud pública de méxico / vol. 58, no. 2, marzo-abril de 2016 Prostate cancer Artículo especiAl P rostate cancer (PC) is the most common cancer and the leading cause of cancer death in men over 50 y in  ...  In 2015, 41 210 cancer deaths are expected among men, 6 801 of which will be from PC. 1 Prostate-specific antigen (PSA) has been applied as a useful marker for the early diagnosis and monitoring of PC.  ...  In 2009, the American group PLCO (Prostate, Lung, Colorectal and Ovarian Screening Trial) and the European group ERSPC (European Randomized Study on Screening for Prostate Cancer) separately published  ... 
doi:10.21149/spm.v58i2.7797 fatcat:upwoct4jx5gyjf6aygkpwzjuni

Prostate Cancer

David F. Penson, June M. Chan
2007 Journal of Urology  
Conclusions: The burden of prostate cancer in the United States is considerable and it appears to have markedly increased in the prostate specific antigen era.  ...  Finally, the total medical expenditure for prostate cancer treatment was $1.3 billion in 2000, which represents a 30% increase over the total expenditure for 1994.  ...  Bradley et al queried a population based cohort of prostate cancer survivors and age matched controls, and found that men with prostate cancer were 10% less likely to be working 6 months after a prostate  ... 
doi:10.1016/j.juro.2007.01.121 pmid:17509282 fatcat:o5ki3f4owvfolekw7r5aguwadu

Prostate Cancer

N J Blacklock
1983 British Journal of Cancer  
For each registry the numbers of cancers per Cancer Incidence in 5 Continents, Vol. IV (Eds J. WATERHOUSE, C. MUIR, K. SHANMUGARATNAM and J.  ...  This volume contains detailed statistics of cancer incidence from eighty-one cancer registers covering various countries or territories in all parts of the world.  ... 
doi:10.1038/bjc.1983.121 pmcid:PMC2011393 fatcat:nmtmhmu3rfal7g7753ot3z424i

Prostate cancer

Stephanie EB McArdle, A Graham Pockley, Glen R Gibson, Robert C Rees
2014 Oncoimmunology  
Prostate cancer: Important steps and considerations in the design of therapeutic vaccines.  ...  Prostate cancer Stephanie We have recently demonstrated the ability of a prostatic acid phosphatase (PAP)-derived 15-mer peptide (PAP-114) to reduce the growth of established TRAMP C1 tumors in a preclinical  ... 
doi:10.4161/onci.28049 pmid:25340006 pmcid:PMC4203569 fatcat:rscmdrcuqvashmtasktt4jpkk4

Prostate Cancer

James Mohler, Robert R. Bahnson, Barry Boston, J. Erik Busby, Anthony D'Amico, James A. Eastham, Charles A. Enke, Daniel George, Eric Mark Horwitz, Robert P. Huben, Philip Kantoff, Mark Kawachi (+13 others)
2010 The Journal of the National Comprehensive Cancer Network  
The Early Prostate Cancer (EPC) trial was the largest prostate cancer trial to date and evaluated bicalutamide, 150 mg daily, as adjuvant therapy in 8113 patients with prostate cancer who were managed  ...  Algorithms Initial Prostate Cancer Diagnosis Initial suspicion of prostate cancer is based on an abnormal DRE or elevated PSA level.  ... 
doi:10.6004/jnccn.2010.0012 pmid:20141676 fatcat:gcy77t7arrayxn7vqatwdz2btu

Prostate Cancer [chapter]

Rajesh Gupta
2017 PET/MR Imaging  
cancer • Treatment related adverse effects Personalized screening schedule • If PSA less than population median for age then consider not re-screening at all or re- screen after 5 years •  ...  100 2001 2002 2004 2006 2008 2010 Year 40 to 49 50 to 59 60 to 69 70 to 79 80 to 99 OUTLINE • PSA screening controversy • How to use PSA more effectively • Treatment of localized prostate  ... 
doi:10.1007/978-3-319-65106-4_86 fatcat:axfudoja3nb4tat7etrtjbwl4e

Prostatic cancer

E P O'Donoghue, G D Chisholm
1976 BMJ (Clinical Research Edition)  
Prostatic cancer If the proposed clinical trials for localised prostatic carcinoma are to yield meaningful results, then detailed investigation to fulfil the TNM requirements concern over this trap  ...  E P N O'DONOGHUE G D CHISHOLM St Peter's Group of Hospitals and Hammersmith Hospital, London I Bailar, J C, III, and Byar, D C, Cancer, 1970, 26, 257. 2 Blackard, C E, Cancer Chemotherapy Reports  ... 
doi:10.1136/bmj.2.6047.1324-e pmid:1000217 pmcid:PMC1689962 fatcat:q7mqafbfzvcfjeiuie3w7nh5dy

Prostate cancer

2016 Nursing Standard  
developing prostate cancer, see Guideline for Klinefelter Syndrome and Cancer.  ...  Drugs The inhibitors of 5-alpha-reductase, i.e. finasteride and dutasteride, reduce the risk for prostate cancer by 20-25%, see Prostate Cancer Study Results.  ... 
doi:10.7748/ns.30.40.17.s20 pmid:27275890 fatcat:yo5nnkdnnfb5vauntmrxigvo4a

Prostate Cancer

Scott Eggener
2011 The Scientific World Journal  
and management of patients with prostate cancer remain enigmatic.  ...  In this Prostate Cancer special issue, our expert authors present and examine clinically relevant topics and look ahead to future research.  ...  Since the introduction of PSA-based prostate cancer screening, the age-adjusted mortality rate from prostate cancer has decreased approximately 40% in the U.S.  ... 
doi:10.1100/tsw.2011.79 pmid:21479346 pmcid:PMC5719996 fatcat:eip2nanskbeodhhb3nss74it5i

Prostate Cancer

R. Pugh
1981 Journal of Clinical Pathology  
In the event the workshop concentrated on the role of hormones and steroid receptors in the development and control of prostate cancer.  ...  cancer.  ... 
doi:10.1136/jcp.34.6.691-b fatcat:dobxcqoegrhg3bkvdu7umuty3a

Prostate cancer

Robert A. Badalament, Joseph R. Drago
1991 Disease-a-month  
PROSTATE CANCER ABSTRACT.— Prostate cancer is the most common malignancy in men and the second leading cause of cancer deaths.  ...  to prostate cancer.  ... 
doi:10.1016/0011-5029(91)90004-u pmid:2019219 fatcat:ospgwp2thzfcjkmbyxmxqrqfda

Prostatic cancer

L A Price, B T Hill
1977 BMJ (Clinical Research Edition)  
It is a depressing fact that only 100% of the currently available antitumour drugs have been adequately tested in prostatic cancer.3 4 Such little experience with chemotherapy in prostatic cancer is regrettable  ...  In our opinion any logical trial aimed at improving the survival time in prostatic cancer should compare local or regional techniques such as surgery or radiotherapy with local therapy plus systemic therapy  ... 
doi:10.1136/bmj.1.6053.105-b pmid:556675 pmcid:PMC1604033 fatcat:fqu4qd6rfzabvn72qypzdslxbq
« Previous Showing results 1 — 15 out of 41,837 results